THYROID CARCINOMA-ASSOCIATED GENETIC MUTATIONS ALSO OCCUR IN THYROID LYMPHOMAS

Molecular testing for mutations activating the mitogen-associated protein kinase signaling pathway is being used to help diagnose thyroid carcinomas. However, the prevalence of these mutations in thyroid lymphomas has not been reported. Therefore, we studied the prevalence of BRAF, NRAS, HRAS, and K...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Aggarwal, Nidhi, Swerdlow, Steven H., Kelly, Lindsey M., Ogilvie, Jennifer B., Nikiforova, Mariana N., Sathanoori, Malini, Nikiforov, Yuri E.
Формат: Artigo
Язык:Inglês
Опубликовано: 2012
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3434253/
https://ncbi.nlm.nih.gov/pubmed/22575864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/modpathol.2012.73
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы